DexTech Medical
5.2
SEK
+6.12 %
Less than 1K followers
DEX
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+6.12%
+28.08%
+25%
+30%
+27.45%
+23.22%
-21.21%
-91.8%
-46.51%
DexTech Medical is a biotechnology research company. Today specialisation is in the area of urologic oncology, where common diseases include prostate cancer. A significant part of the research is carried out in collaboration with international players, research institutes and universities. The company was established in 2004 and is based in Uppsala.
Read moreMarket cap
96.13M SEK
Turnover
22.36K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
30/8
2025
Annual report '25
3/11
2025
Interim report Q1'26
4/11
2025
General meeting '25
All
Press releases
ShowingAll content types
DexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved
DexTech Medical AB, Delårsrapport 1 juli, 2024 - 31 mars 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools